Dna X (SONM) Retained Earnings (2018 - 2025)
Historic Retained Earnings for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to -$295.4 million.
- Dna X's Retained Earnings fell 1274.23% to -$295.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$295.4 million, marking a year-over-year decrease of 1274.23%. This contributed to the annual value of -$283.6 million for FY2024, which is 1346.14% down from last year.
- Per Dna X's latest filing, its Retained Earnings stood at -$295.4 million for Q3 2025, which was down 1274.23% from -$290.6 million recorded in Q2 2025.
- Dna X's 5-year Retained Earnings high stood at -$205.5 million for Q1 2021, and its period low was -$295.4 million during Q3 2025.
- In the last 5 years, Dna X's Retained Earnings had a median value of -$249.6 million in 2023 and averaged -$252.0 million.
- Its Retained Earnings has fluctuated over the past 5 years, first crashed by 1968.98% in 2021, then grew by 8.92% in 2023.
- Dna X's Retained Earnings (Quarter) stood at -$234.8 million in 2021, then decreased by 6.42% to -$249.9 million in 2022, then dropped by 0.04% to -$250.0 million in 2023, then fell by 13.46% to -$283.6 million in 2024, then fell by 4.15% to -$295.4 million in 2025.
- Its Retained Earnings stands at -$295.4 million for Q3 2025, versus -$290.6 million for Q2 2025 and -$283.2 million for Q1 2025.